Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

ACR Convergence 2021: Advocacy Successes & Challenges

Thomas R. Collins  |  October 25, 2021

The ACR’s advocacy efforts over the past year have helped bring to Congress important legislation that could have effects felt by clinics and patients around the country, but there is plenty of work ahead to push the measures across the finish line.

Leaders in government affairs for the ACR will describe this progress and needed efforts in an ACR Convergence 2021 session, Make Your Voice Count: Annual Advocacy Update, scheduled for Sunday, Nov. 7, at 11 a.m. EST.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The session will be moderated by Ryan Jessee, MD, a member of the ACR’s Government Affairs Committee (GAC) and clinical associate professor of rheumatology at Duke University School of Medicine, Durham, N.C. GAC Chair Elizabeth (Blair) Solow, MD, will talk about the strides made over the past year. Amanda Wiegrefe, the ACR director of regulatory affairs, and Lennie McDaniel, JD, the ACR director of congressional affairs, will discuss legislative challenges the College will face in the coming year. Amy Barron, RN, will discuss advocacy from a patient’s perspective, and Daniel Redinger, the ACR’s manager of advocacy and political affairs, will give attendees an “advocacy toolkit,” a basic how-to for driving policy changes meaningful to rheumatologists and patient care.

“This is a chance to celebrate our achievements as well as let people know about upcoming challenges,” Dr. Jessee says, “and then also educate members on ways, both big and small, in which they can become involved and help their profession as well as themselves from an advocacy standpoint.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The patient’s perspective is a new addition to the annual session. “We wanted to broaden the appeal and make it clear to everyone that advocacy is something that’s done not just by providers, but patients as well,” Dr. Jessee says. “Most of our issues affect providers and patients, whether it’s access to care or being able to afford medications or see the provider you need.”

Legislative Highlights

Ms. McDaniel says the biggest advocacy accomplishment over the past year was the reintroduction of the Improving Seniors’ Timely Access to Care Act, which puts up guardrails to safeguard care that might be threatened by prior authorization requirements that force a physician to get insurer authorization before treatment can be given to a patient. Too often, she says, this process results in patients going to the pharmacy for a medication “and finding out that they can’t pick it up because the prior authorization hasn’t gone through.” This frequently leads to delays in treatment and, sometimes, in patients never getting their medication at all because they find the process too burdensome.

Page: 1 2 | Single Page
Share: 

Filed under:ACR ConvergenceLegislation & AdvocacyMeeting Reports Tagged with:ACR advocacyACR Convergence 2021Legislation & Advocacyprior authorizationRyan Jessee

Related Articles
    Dorothy.Wedel / shutterstock.com

    How Duke’s School of Medicine Implemented a Quality Improvement Curriculum

    July 15, 2020

    It has been about 20 years since the Institute of Medicine (now the National Academy of Medicine) published the report To Err Is Human: Building a Safer Health System, shining light on the impact of medical errors in healthcare.1 In response to that publication, the focus on quality improvement (QI) started in the inpatient setting,…

    Speak Up: Ask Congress to Block Medicare Reimbursement Cuts

    October 22, 2021

    Rheumatologists may need to downsize and restrict patient care if Congress doesn’t act to block significant cuts to Medicare reimbursement rates totaling 9.75% in 2022.

    Persistence Pays Off: 2021 Midyear Advocacy Update

    May 21, 2021

    Sequestration, workforce issues and step therapy reform are just some of the areas in which the ACR’s activities, via the Government Affairs Committee and member action, have made a positive difference for rheumatology practitioners.

    ACR Advocacy: 2021 Midyear Update

    June 13, 2021

    Beginning in the late 1800s, Eliza Ruhamah Scidmore, U.S. diplomat and writer, spent 24 years advocating for sakura, or Japanese cherry trees, to be planted in Washington, D.C. After unsuccessfully petitioning every U.S. Army Superintendent of Public Buildings and Grounds for over two decades, she wrote a letter to First Lady Helen Herron Taft about…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences